Print

MABGEL1

A randomised double-blind phase 1 study to assess the pharmacokinetics of C2F5, C2G12 and C4E10 when administered together in a gel vehicle as a vaginal microbicide

Trial Details:

I Completed
York Hospitals NHS Foundation Trust (UK) April 01, 2009
C2F5, C2G12 and C4E10 2F5, 2G12 and 4E10 antibodies
C2F5, C2G12 and C4E10 Passive Immunization
United Kingdom 28
N/A
http://www.isrctn.com/ISRCTN64808733